key: cord-1013342-kzotzxyh
authors: Shin, E.-C.; Jung, J. H.; Rha, M.-S.; Sa, M.; Choi, H. K.; Jeon, J. H.; Seok, H.; Park, D. W.; Park, S.-H.; Jeong, H. W.; Choi, W. S.
title: SARS-CoV-2-specific T Cell Memory is Sustained in COVID-19 Convalescents for 8 Months with Successful Development of Stem Cell-like Memory T Cells
date: 2021-03-08
journal: nan
DOI: 10.1101/2021.03.04.21252658
sha: e1472b5644102c9df209874e219a1cac29662bd2
doc_id: 1013342
cord_uid: kzotzxyh

Memory T cells contribute to rapid viral clearance during re-infection, but the longevity and differentiation of SARS-CoV-2-specific memory T cells remain unclear. We conducted direct ex vivo assays to evaluate SARS-CoV-2-specific CD4+ and CD8+ T cell responses in COVID-19 convalescents up to 254 days post-symptom onset (DPSO). Here, we report that memory T cell responses were maintained during the study period. In particular, we observed sustained polyfunctionality and proliferation capacity of SARS-CoV-2-specific T cells. Among SARS-CoV-2-specific CD4+ and CD8+ T cells detected by activation-induced markers, the proportion of stem cell-like memory T (T SCM) cells increased, peaking at approximately 120 DPSO. Development of TSCM cells was confirmed by SARS-CoV-2-specific MHC-I multimer staining. Considering the self-renewal capacity and multipotency of TSCM cells, our data suggest that SARS-CoV-2-specific T cells are long-lasting after recovery from COVID-19. The current study provides insight for establishing an effective vaccination program and epidemiological measurement.

Introduction 7 on average until 60 DPSO and was maintained thereafter (Fig. 3d) . The proportion of CCR7 -136 CD45RA + (TEMRA) cells and CCR7 + CD45RA + cells was maintained (~25% and 25-35% on 137 average, respectively) during the study period (Fig. 3d) . 138 We further investigated whether CCR7 + CD45RA + cells include TSCM cells, which have 139 a self-renewal capacity and multipotency for differentiation into diverse T cell subsets, by 140 examining CD95, a marker of TSCM cells 15, 16 . In both AIM + CD4 + and AIM + CD8 + T cells, CD95 + 141 cells were a dominant population among CCR7 + CD45RA + cells (Fig. 3e) , indicating that the 142 CCR7 + CD45RA + cells among AIM + CD4 + or AIM + CD8 + T cells are mainly TSCM cells. The 149 150 To validate the results from in vitro stimulation-based AIM assays, we detected 151 SARS-CoV-2-specific CD8 + T cells by performing direct ex vivo MHC-I multimer staining and 152 examined the differentiation status of MHC-I multimer + cells. We used an HLA-A*02 153 multimer loaded with SARS-CoV-2 S269 (YLQPRTFLL) peptide that has a low degree of 154 homology to the human common cold coronaviruses (ccCoVs) 22,23 . MHC-I multimer + cells 155 were detected during the study period until 234 DPSO (Fig. 4a, b) , and we determined the 156 proportions of TCM (CCR7 + CD45RA -), TEM (CCR7 -CD45RA -), TEMRA (CCR7 -CD45RA + ), and TSCM 8 multimer + cells was high 60 -125 DPSO. 167 A recent study has revealed two distinct subsets of CCR7 + stem cell-like progenitors: 168 CCR7 + PD-1 -TIGITcells with stem cell-like features and CCR7 + PD-1 + TIGIT + cells with exhausted 169 traits 24 . Therefore, we examined the expression of PD-1 and TIGIT in SARS-CoV-2-specific SARS-CoV-2-specific TSCM cells than among total CD8 + T cells (Fig. 4e) , confirming that SARS- Considering preserved polyfunctionality and proliferation capacity of SARS-CoV-2-195 specific memory T cells, the current data indicate that memory T cells contribute to 196 protective immunity against re-infection even 8 months after the primary infection.

197 All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Polyfunctional T cells, which exert multiple effector functions simultaneously, play a 259 All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. 277 In this study, 94 patients with PCR-confirmed SARS-CoV-2 infection were enrolled 278 from Ansan Hospital and Chungbuk National University Hospital, Republic of Korea.

Peripheral blood was obtained from all patients with SARS-CoV-2 infection. We also obtained 280 peripheral blood from seven healthy donors. In six asymptomatic patients, the date of the (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. SARS-CoV-2-specific CD8 + T cells All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Statistical analysis was performed using the Kruskal-Wallis test with Dunns' multiple comparisons test. n.s, not significant.

PD-1-Expressing SARS-CoV-2-Specific CD8(+) T Cells Are Not Exhausted, but Functional 421 in Patients with COVID-19

Two subsets of stem-like CD8(+) memory T cell progenitors with distinct fate 423 commitments in humans

Cellular Immunity in COVID-19 Convalescents with PCR-Confirmed Infection but 425 with Undetectable SARS-CoV-2-Specific IgG

Rapid Decay of Anti-SARS-CoV-2 Antibodies in Persons with Mild Covid-19

Persistence of serum and saliva antibody responses to SARS-CoV-2 spike antigens in 429 COVID-19 patients

Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections

Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans

SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell 435 recognition

Healthy donor T cell responses to common cold coronaviruses and SARS-437

SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19